1 min read

HeartLung's distinguished advisor, Dr. Claudia Henschke, who pioneered lung cancer screening, wins the RSNA 2024 Scientific Excellence Award 🏆⚕️

Congratulations to Dr. Claudia Henschke! 🎉

HeartLung collaborator, Dr. Claudia Henschke, has been honored with the prestigious Scientific Excellence Award at #RSNA2024! 🏆 Her pioneering contributions to #LungCancerScreening and #EarlyDetection have revolutionized the field. Congratulations, Dr. Henschke, on this well-earned recognition! 👏

Read More

Recent Posts

See All

Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 - Opening Remarks: CVD Burden in 2050 without New Prevention Strategies

Video Presentations of the 1st Conference on "Integrating Early Detection of Heart and Lung Disease through Low-Dose CT" are now available for the public: Day 1 - Welcome and Introduction

HeartLung Technologies to Present Four Scientific Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at the 2024 Radiological Society of North America (RSNA 2024)

HeartLung's distinguished advisor, Dr. Claudia Henschke, who pioneered lung cancer screening, wins the RSNA 2024 Scientific Excellence Award 🏆⚕️

Recent Posts

Comments

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

©2024 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686. and Patents Pending. AutoBMD™, AutoCAC™, AutoChamber™ and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.